Back to today’s briefing

Story perspectives

European Stocks Rise Amid U.S. Tariff Changes

9/26/2025

36 8 Full Breakdown

Summary

Story summary

European stocks rose as investors react to United States trade policy changes, with the Stoxx 600 up 0.5%.
President Trump announced a 100% tariff on pharmaceutical imports starting Oct. 1, exempting U.S. manufacturers.
Healthcare stocks fluctuated, with Zealand Pharma down 2.9%, and Novo Nordisk down 1.6%.
JP Morgan analysts say tariff impact should be manageable due to potential U.S. manufacturing.

History

Historical Context

In 2018, the U.S. government, led by President Trump, imposed tariffs on various imports, including a 100% tariff on pharmaceuticals, affecting companies like Zealand Pharma and Novo Nordisk. This move echoes the Smoot-Hawley Tariff Act of 1930, which raised duties on over 20,000 goods, highlighting ongoing trade tensions that could reshape international trade relationships and domestic manufacturing strategies.

1 of 2

Story summary

European stocks rose as investors react to United States trade policy changes, with the Stoxx 600 up 0.5%.
President Trump announced a 100% tariff on pharmaceutical imports starting Oct. 1, exempting U.S. manufacturers.
Healthcare stocks fluctuated, with Zealand Pharma down 2.9%, and Novo Nordisk down 1.6%.
JP Morgan analysts say tariff impact should be manageable due to potential U.S. manufacturing.

1 / 2